Profile picture

Doctor Karl-Philipp Rommel

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)
Membership: HFA Member
Follow
Logo ESC

Contributor content

Addressing the elephant in the room – atrial shunt therapies and effect on right heart function
Presentation
Addressing the elephant in the room – atrial shunt therapies and effect on right heart function
Two-year outcomes of mitral transcatheter edge-to-edge repair in patients with heart failure and functional mitral regurgitation from the MiCLASP Study
Presentation
Two-year outcomes of mitral transcatheter edge-to-edge repair in patients with heart failure and functional mitral regurgitation from the MiCLASP Study
Right ventricular to pulmonary artery coupling in tricuspid regurgitation and implications of transcatheter tricuspid valve repair in a propensity score matched analysis
Presentation
Right ventricular to pulmonary artery coupling in tricuspid regurgitation and implications of transcatheter tricuspid valve repair in a propensity score matched analysis
Functional volume distribution in tricuspid regurgitation associated right heart failure
Presentation
Functional volume distribution in tricuspid regurgitation associated right heart failure
Right ventricular form and function in heart failure with preserved ejection fraction. The HFpEF PHT Study.
Presentation
Right ventricular form and function in heart failure with preserved ejection fraction. The HFpEF PHT Study.
Impact of pulmonary hypertension on procedural and clinical outcomes in patients with right heart failure and tricuspid tegurgitation undergoing transcatheter edge-to-edge repair
Presentation
Impact of pulmonary hypertension on procedural and clinical outcomes in patients with right heart failure and tricuspid tegurgitation undergoing transcatheter edge-to-edge repair
Phosphodiesterase 9A - novel biomarker or potential therapeutic target in patients with heart failure and preserved ejection fraction?
Presentation
Phosphodiesterase 9A - novel biomarker or potential therapeutic target in patients with heart failure and preserved ejection fraction?
Genome-wide gene expression analysis reveals pathomechanisms in patients with heart failure and preserved ejection fraction (HFpEF) - Insights from the Leipzig Heart Study
Presentation
Genome-wide gene expression analysis reveals pathomechanisms in patients with heart failure and preserved ejection fraction (HFpEF) - Insights from the Leipzig Heart Study
Relation of right ventricular function abnormalities to the presence of pulmonary hypertension in heart failure with preserved ejection fraction. Insights from invasive pressure-volume analysis.
Presentation
Relation of right ventricular function abnormalities to the presence of pulmonary hypertension in heart failure with preserved ejection fraction. Insights from invasive pressure-volume analysis.
Abnormal right ventricular reserve capacity in patients with heart failure and preserved biventricular function is caused by ventricular stiffness, impaired relaxation and vascular stiffness.
Presentation
Abnormal right ventricular reserve capacity in patients with heart failure and preserved biventricular function is caused by ventricular stiffness, impaired relaxation and vascular stiffness.

ESC 365 is supported by